Quality and outcomes in global cancer surgery.

Not Applicable

Completed

• Conditions: Health Condition 1: K319- Disease of stomach and duodenum, unspecified

• Registration Number: CTRI/2018/11/016251
• Lead Sponsor: Tata memorial Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2021-12-29
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 782

Inclusion Criteria

All consecutive patients undergoing therapeutic surgery curative or palliative for breast gastric and colorectal cancer should be included

Surgery is defined as a procedure requiring a skin incision performed under general or neuraxial eg regional epidural or spinal anaesthesia

Both elective and emergency procedures should be included

Include patients in whom the pre operative diagnosis was thought to be benign but was subsequently found to be cancer eg bowel obstruction found to be due to

cancer during surgery

Include patients in whom the pre-�­operative diagnosis was thought to be cancer but was subsequently found to be benign disease ensure the pathology variable indicates not cancer will not be included in primary analysis

Laparoscopic laparoscopic converted robotic and open cases should be included

Patients aged 18 years and over should be included

Surgery may be with curative or palliative intent Include patients in whom curative surgery was attempted but abandoned eg open close laparotomy

Exclusion Criteria

Operations where breast gastric or colorectal cancer is not suspected to be the

primary pathology should be excluded

Patients undergoing a procedure purely for diagnosis or staging should be excluded

eg open breast biopsy staging laparoscopy

Patients undergoing a procedure which does not require a skin incision should be

excluded eg colonoscopy endoscopy alone chemo radiotherapy alone

Patients with recurrence of breast colorectal or gastric cancer should be excluded

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality and complication rates after cancer surgery.Timepoint: 30 days

Secondary Outcome Measures

Name	Time	Method
Cancer-�­specific quality measuresTimepoint: 30 days